相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trimethoprim-Sulfamethoxazole-Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System A Population-Based Study
Tony Antoniou et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring
Marsha A. Raebel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates
Marsha A. Raebel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril
Eric S. Johnson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease
William L. Baker et al.
ANNALS OF INTERNAL MEDICINE (2009)
Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
Joy M. Weinberg et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Effects of presentation and electrocardiogram on time to treatment of hyperkalemia
Kalev Freeman et al.
ACADEMIC EMERGENCY MEDICINE (2008)
Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Serum Potassium Levels and Renal Function in Ambulatory Outpatients: Risk Factors Analysis
Supriya Maddirala et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Pseudohyperkalemia in Serum: A New Insight into an Old Phenomenon
Nikolaos Sevastos et al.
CLINICAL MEDICINE & RESEARCH (2008)
Incidence and predictors of hyperkalemia in patients with heart failure
Akshay S. Desai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
Marsha A. Raebel et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: A retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
Simon de Denus et al.
AMERICAN HEART JOURNAL (2006)
Improved therapeutic monitoring with several interventions - A randomized trial
Adrianne C. Feldstein et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients
MA Raebel et al.
PHARMACOTHERAPY (2006)
Follow-up of markedly elevated serum potassium results in the ambulatory setting: Implications for patient safety
CR Moore et al.
AMERICAN JOURNAL OF MEDICAL QUALITY (2006)
Efficacy and safety of benazepril for advanced chronic renal insufficiency
FF Hou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Laboratory monitoring of drugs at initiation of therapy in ambulatory care
MA Raebel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Improving laboratory monitoring at initiation of drug therapy in ambulatory care - A randomized trial
MA Raebel et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult - Summary article
SA Hunt et al.
CIRCULATION (2005)
Disorders of potassium
TJ Schaefer et al.
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA (2005)
Clinical factors associated with hyperkalemia in patients with congestive heart failure
FH Ramadan et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2005)
Brief report: Laboratory safety monitoring of chronic medications in ambulatory care settings
JS Hurley et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications
G Wolf et al.
KIDNEY INTERNATIONAL (2005)
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Diabetes may be independent risk factor for hyperkalaemia
PR Jarman et al.
BRITISH MEDICAL JOURNAL (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin
G Gheno et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Drug-drug interactions among elderly patients hospitalized for drug toxicity
DN Juurlink et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Current concepts: Renal dysfunction complicating the treatment of hypertension
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Labetalol-induced hyperkalemia in renal transplant recipients
J McCauley et al.
AMERICAN JOURNAL OF NEPHROLOGY (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
LH Lindholm et al.
LANCET (2002)
Drug-induced hyperkalemia
L Pantanowitz
AMERICAN JOURNAL OF MEDICINE (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Hypokalaemia and hyperkalaemia
A Rastergar et al.
POSTGRADUATE MEDICAL JOURNAL (2001)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
SA Hunt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone
C Berry et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Quality indicators for appropriate medication use in vulnerable elders
EL Knight et al.
ANNALS OF INTERNAL MEDICINE (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data
TH Jafar et al.
ANNALS OF INTERNAL MEDICINE (2001)
Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases
H Schepkens et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure - Results from the ATLAS trial
BM Massie et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
GL Bakris et al.
KIDNEY INTERNATIONAL (2000)
Preserving renal function in adults with hypertension and diabetes: A consensus approach
GL Bakris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors
TS Ahuja et al.
AMERICAN JOURNAL OF NEPHROLOGY (2000)
Indications for hospitalization of patients with hyperkalemia
D Charytan et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II
B Pitt et al.
LANCET (2000)
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?
GL Bakris et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Herbal interactions with cardiac drugs
TO Cheng
ARCHIVES OF INTERNAL MEDICINE (2000)
Noni juice (Morinda citrifolia):: Hidden potential for hyperkalemia?
BA Mueller et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Drug-induced hyperkalemia: Old culprits and new offenders
MA Perazella
AMERICAN JOURNAL OF MEDICINE (2000)
分享论文
